The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Some stimulatory receptors of the innate immune system, such as the NKG2D receptor (also called KLRK1) expressed by natural killer cells and activated CD8(+)T cells, recognize self-molecules that are upregulated in diseased cells by poorly understood mechanisms. Here we show that mouse and human NKG2D ligands are upregulated in non-tumour cell lines by genotoxic stress and stalled DNA replication, conditions known to activate a major DNA damage checkpoint pathway initiated by ATM (ataxia telangiectasia, mutated) or ATR (ATM- and Rad3-related) protein kinases. Ligand upregulation was prevented by pharmacological or genetic inhibition of ATR, ATM or Chk1 (a downstream transducer kinase in the pathway). Furthermore, constitutive ligand expression by a tumour cell line was inhibited by targeting short interfering RNA to ATM, suggesting that ligand expression in established tumour cells, which often harbour genomic irregularities, may be due to chronic activation of the DNA damage response pathway. Thus, the DNA damage response, previously shown to arrest the cell cycle and enhance DNA repair functions, or to trigger apoptosis, may also participate in alerting the immune system to the presence of potentially dangerous cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, genomic damage—a common cause of cellular senescence—induces expression of the membrane-bound ligands for the major natural killer cell receptor NKG2D (140).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [140]
The cited source says what the claim attributes to it.
In the citing paper
“other evidence indicates that the immune system's recognition of tumour cells might require the continuous activation of the DDR pathway 13”
From The common biology of cancer and ageing (2007) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Further, DNA damage or activation of oncogenes can induce cellular senescence, through a pathway that relies, in part, on the secretion of pro-inflammatory cytokines such as insulin-like growth factor binding protein-7 (IGFBP7)32 and IL-633, and on the secretion of CXC-chemokine ligand 8 (CXCL8) and other chemokines 33,34, as well as on the expression of the CXCL8 receptor CXC-chemokine receptor 2”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredIn the citing paper
“These findings are consistent with previous studies suggesting that NKG2D ligands are induced by a variety of other stimuli, including E2F transcription factors, PI3 kinase, Ras oncogene signaling, and an activated DNA damage response (Gasser et al., 2005; Tokuyama et al., 2011; Jung et al., 2012).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Gasser et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: p73α Regulation by Chk1 in Response to DNA Damage
Gonzalez, S., Prives, C., & Cordon-Cardo, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8161-8171.2003 · Cited by 75
RetractedDNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Self-citation(1999) · PubMed · Cited by 1,030
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Self-citation
Cited by
Items 601–700 of 1,000
Vassena, L., Giuliani, E., Matusali, G., Cohen, É. A., & Doria, M. (2013) · Journal of General Virology · doi:10.1099/vir.0.055541-0 · Cited by 41
“…NKG2D and DNAM-1 ligands is induced by the DNA damage response (DDR) pathway, specifically by the activation of the DNA damage sensor kinases ATM (ataxia telangiectasia-mutated) and ATR (ATM and Rad3-related) (Ardolino et al., 2011; Cerboni et al., 2007a; Gasser et al., 2005; Soriani et al., 2009).”
BackgroundNK cells interactions with dendritic cells shape innate and adaptive immunity.
Brilot, F., Strowig, T., & Münz, C. (2008) · Frontiers in Bioscience · doi:10.2741/3165 · Cited by 45
“They include non-classical MHC class I molecules (MHC class I polypeptide-related sequence A or B, MICA and MICB in humans), and the MHC class I-related UL-16 binding proteins (ULBP) 1-4 which are induced in viral infections, during transformation, and by DNA-damaging agents (35, 36).”
BackgroundAgüera‐González, S., Boutet, P., Reyburn, H. T., & Valés‐Gómez, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800713 · Cited by 39
Walshaw, R. C., Honeychurch, J., & Illidge, T. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160472 · Cited by 41
NKG2D ligands in glioma stem-like cells: expression in situ and in vitro
Flüh, C., Chitadze, G., Adamski, V., Hattermann, K., Synowitz, M., Kabelitz, D., & Held‐Feindt, J. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1633-5 · Cited by 39
Engineered NK Cells Against Cancer and Their Potential Applications Beyond
Karvouni, M., Vidal-Manrique, M., Lundqvist, A., & Alici, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.825979 · Cited by 40
“The mechanism of upregulation of NK cell activating ligands is not fully elucidated, although increasing evidence suggests transcriptional and posttranslational modifications taking place as a result of cell response to stressful stimuli and DNA damage (4, 5).”
BackgroundNK cell defects: implication in acute myeloid leukemia
D’Silva, S. Z., Singh, M. M., & Pinto, A. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1112059 · Cited by 38
Immunotherapy in gliomas: limitations and potential of natural killer (NK) cell therapy
Ogbomo, H., Cinatl, J. J., Mody, C. H., & Forsyth, P. A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.03.004 · Cited by 40
Hagemann-Jensen, M., Uhlenbrock, F., Kehlet, S. N., Andresen, L. O., Gabel‐Jensen, C., Ellgaard, L., Gammelgaard, B., & Skov, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.591537 · Cited by 39
Sullivan, L. C., Shaw, E. M., Stankovic, S., Snell, G. I., Brööks, A. G., & Westall, G. P. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1078 · Cited by 38
Lama-Sherpa, T. D., & Shevde, L. A. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0665 · Cited by 41
“Genotoxic agents stimulate NKG2D ligand expression on mice and human tumor cell lines (77).”
BackgroundThe two-faces of NK cells in oncolytic virotherapy
Marotel, M., Hasim, M. S., Hagerman, A., & Ardolino, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.005 · Cited by 37
Huang, M., Sun, R., Wei, H., & Tian, Z. (2012) · Hepatology · doi:10.1002/hep.25959 · Cited by 37
Immune suppression in renal cell carcinoma
Frankenberger, B., Noeßner, E., & Schendel, D. J. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.06.004 · Cited by 40
Andresen, L. O., Hansen, K. A., Jensen, H., Pedersen, S. F., Stougaard, P., Hansen, H. R., Jurlander, J., & Skov, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803014 · Cited by 37
“have shown that ATM/ATR activity is involved in NKG2D ligand expression following DNA damage response (10).”
BackgroundCancer Immunoediting of the NK Group 2D Ligand H60a
O’Sullivan, T. E., Dunn, G. P., LaCoursiere, D. Y., Schreiber, R. D., & Bui, J. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100413 · Cited by 37
“It binds a ligand family that is generally not expressed at functional levels in normal tissues but can be upregulated by certain stimuli, including DNA damage and virus infection (10, 15).”
BackgroundNatural killer cell evasion by an E3 ubiquitin ligase from Kaposi's sarcoma-associated herpesvirus
Thomas, M., Wills, M. R., & Lehner, P. J. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360459 · Cited by 37
Gamma delta T cells and their immunotherapeutic potential in cancer
Cieslak, S. G., & Shahbazi, R. (2025) · Biomarker Research · doi:10.1186/s40364-025-00762-6 · Cited by 38
“These ligands, which are regulated by the DNA damage response pathway, interact with the innate activating receptor NKG2D, which is expressed by γδ T cells, CD8 + αβ T cells, and NK cells [12, 136].”
CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells
Sauer, M., Schuldner, M., Hoffmann, N., Cetintas, A., Reiners, K. S., Shatnyeva, O., Hallek, M. J., Hansen, H. P., Gasser, S., & von Strandmann, E. P. (2016) · Oncogene · doi:10.1038/onc.2016.259 · Cited by 38
Self-citationZoine, J. T., Knight, K. A., Fleischer, L. C., Sutton, K. S., Goldsmith, K. C., Doering, C. B., & Spencer, H. T. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1593804 · Cited by 39
“Prior studies have shown that chemotherapy induces the expression of stress antigens such as, MHC class I chain-related protein A or protein B (MICA/B) or UL16binding proteins (ULBPs), on the tumor cell surface, increasing tumor cell vulnerability.(43) By increasing susceptibility of cancer cells to recognition via th…”
BackgroundInsights Into Mechanisms of Tumor and Immune System Interaction: Association With Wound Healing
Ponomarev, А. V., & Shubina, I. Z. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01115 · Cited by 40
“MICA/B expression increased in non-tumor cell lines in various stress conditions including DNA damage (46) and viral infection (47).”
BackgroundLamberti, G., Andrini, E., Sisi, M., Federico, A. D., & Ricciuti, B. (2020) · Future Oncology · doi:10.2217/fon-2020-0215 · Cited by 36
Establishing Linkages Among DNA Damage, Mutagenesis, and Genetic Diseases
Basu, A. K., & Essigmann, J. M. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00155 · Cited by 37
Iwakawa, M., Ohno, T., Imadome, K., Nakawatari, M., Ishikawa, K.-I., Sakai, M., Katoh, S., Ishikawa, H., Tsujii, H., & Imai, T. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.6.4098 · Cited by 36
Cytomegalovirus and Tumors: Two Players for One Goal-Immune Escape
Lepiller, Q. (2011) · The Open Virology Journal · doi:10.2174/1874357901105010060 · Cited by 38
“Conversely, expression of NKG2DLs was upregulated in stressed cells with DNA damages [41].”
BackgroundImmune and inflammatory responses to DNA damage in cancer and aging
Soria-Valles, C., López-Soto, A., Osorio, F. G., & López-Otín, C. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.10.004 · Cited by 36
Chang, C., & Ferrone, S. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.001 · Cited by 38
Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer
Sandoval, T. A., Salvagno, C., Chae, C.-S., Awasthi, D., Giovanelli, P., Falco, M. M., Hwang, S., Terán-Cabanillas, E., Suominen, L., Yamazaki, T., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1451 · Cited by 35
“Of note, these pathways have been shown to mediate the induction of NKG2D ligands on cancer cells undergoing canonical DNA damage (42).”
Hosomi, S., Grootjans, J., Huang, Y., Kaser, A., & Blumberg, R. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01324 · Cited by 37
“In both mouse and human non-tumor cells, genotoxic stress and inhibition of DNA replication via the DNA damage pathway through ATM or ATR protein kinases, leads to increased surface expression of NKG2D-ligands (55).”
BackgroundNK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells
Babić, M., Dimitropoulos, C., Hammer, Q., Stehle, C., Heinrich, F., Sarsenbayeva, A., Eisele, A. S., Durek, P., Mashreghi, M., Lisnić, B., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190133 · Cited by 36
Radiotherapy transiently reduces the sensitivity of cancer cells to lymphocyte cytotoxicity
Tuomela, K., Mukherjee, D., Ambrose, A. R., Harikrishnan, A., Mole, H., Hurlstone, A. F. L., Önfelt, B., Honeychurch, J., & Davis, D. M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111900119 · Cited by 36
Wahle, J. A., Paraiso, K. H. T., Costello, A. L., Goll, E. L., Sentman, C. L., & Kerr, W. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7165 · Cited by 35
Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer
Arina, A., Murillo, O., Dubrot, J., Azpilikueta, A., Alfaro, C., Perez‐Gracia, J. L., Bendandi, M., Palencia, B., Hervás‐Stubbs, S., & Melero, I. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.5.599 · Cited by 39
“[64] demonstrated that DNA damage pathways regulate NKG2D ligand expression that the linkage was proven.”
BackgroundTargets of Protective Tumor Immunity
Dranoff, G. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04938.x · Cited by 36
Jeong, J., Uong, T. N. T., Chung, W., Nam, T., Ahn, S., Song, J., Kim, S., Shin, D., Cho, E., Kim, K. W., et al. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.01.010 · Cited by 35
Kim, J.-Y., Bae, J., Lee, S.-H., Lee, E.-Y., Chung, B., Kim, S.-H., & Kang, C. (2008) · Journal of immunotherapy · doi:10.1097/cji.0b013e3181755deb · Cited by 34
Huang, Y., Chen, X., Guo, K., Li, Y., Wu, B., Song, C.-Y., & He, Y. (2017) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000168 · Cited by 34
Telomeric impact of conventional chemotherapy
Lu, Y., Leong, W., Guérin, O., Gilson, É., & Ye, J. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0293-z · Cited by 37
“In addition, senescent cells can be eliminated by natural killer (NK) cells [1] and it was described by Raulet and Gasser that DDR induction by various stresses including chemical stress, UV irradiation or chemotherapy induces the up-regulation of NK cells activating ligands at the surface of the stressed cells leadin…”
BackgroundSun, Y., Zheng, Z., Zhang, H., Yu, Y., Ma, J., Tang, K., Xu, P., Ji, T., Liang, X., Chen, D., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1309487 · Cited by 36
Translating the anti-myeloma activity of Natural Killer cells into clinical application
Fionda, C., Stabile, H., Molfetta, R., Soriani, A., Bernardini, G., Zingoni, A., Gismondi, A., Paolini, R., Cippitelli, M., & Santoni, A. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.10.005 · Cited by 36
cGAS in nucleus: The link between immune response and DNA damage repair
Song, J.-X., Villagomes, D., Zhao, H., & Zhu, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1076784 · Cited by 36
“The DNA damage repair factor ATM/ATR/Chk1 is required for the upregulation of NKG2DL, an innate immune system ligand for the NKG2D receptor (113).”
BackgroundSoriani, A., Borrelli, C., Ricci, B., Molfetta, R., Zingoni, A., Fionda, C., Carnevale, S., Abruzzese, M. P., Petrucci, M. T., Ricciardi, M. R., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1264564 · Cited by 34
Anti-NKG2D mAb: A New Treatment for Crohn’s Disease?
Vadstrup, K., & Bendtsen, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091997 · Cited by 37
“In some cases, ligands may be induced due to the genomic instability of the transformed cells, resulting in activation of DNA repair pathways [60], but the factors causing NKG2D ligand expression depend on the transformed cells, as well as exposure to cytokines and other factors in the microenvironment [38].”
BackgroundCAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
Zhu, X., Xue, J., Jiang, H., & Xue, D. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02151-3 · Cited by 33
“Additionally, radiation-induced DNA damage can lead to the expression of NKG2D ligands on tumor cells, potentially enhancing NK cells’ activation and cytotoxicity against tumor cells [155, 156].”
BackgroundPaschen, A., Baingo, J., & Schadendorf, D. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.01.009 · Cited by 35
Leveraging Natural Killer Cells for Cancer Immunotherapy
Grossenbacher, S. K., Aguilar, E. G., & Murphy, W. J. (2017) · Immunotherapy · doi:10.2217/imt-2017-0013 · Cited by 33
Goulding, J., Yeh, W.-I., Hancock, B., Blum, R., Xu, T., Yang, B.-H., Chang, C., Groff, B. C., Avramis, E. V., Pribadi, M., et al. (2023) · Med · doi:10.1016/j.medj.2023.04.004 · Cited by 35
Direct Interaction of the Mouse Cytomegalovirus m152/gp40 Immunoevasin with RAE-1 Isoforms
Li, Z., Mans, J., Paskow, M. J., Brown, P. H., Schuck, P., Jonjić, S., Natarajan, K., & Margulies, D. H. (2010) · Biochemistry · doi:10.1021/bi902130j · Cited by 33
“NKG2D is found on a variety of immune effector cells including NK cells, antigen-experienced CD8+ T cells, γδ T cells, and some activated CD4+ T cells (10-12).”
BackgroundRNA-binding proteins regulate the expression of the immune activating ligand MICB
Nachmani, D., Gutschner, T., Reches, A., Diederichs, S., & Mandelboim, O. (2014) · Nature Communications · doi:10.1038/ncomms5186 · Cited by 36
Checkpoint kinase 1 is essential for meiotic cell cycle regulation in mouse oocytes
Chen, L., Chao, S.-B., Wang, Z.-B., Qi, S., Zhu, X.-L., Yang, S.-W., Yang, C., Zhang, Q.-H., Ouyang, Y., Hou, Y., et al. (2012) · Cell Cycle · doi:10.4161/cc.20279 · Cited by 33
Antoun, A., Jobson, S., Cook, M. A., O’Callaghan, C. A., Moss, P. A. H., & Briggs, D. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.02.018 · Cited by 33
Basu, S., Eriksson, M., Pioli, P. A., Conejo-Garcia, J. R., Mselle, T., Yamamoto, S., Wira, C. R., & Sentman, C. L. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2008.00661.x · Cited by 33
Shen, Y., Lü, C., Tian, W., Wang, L., Cui, B., Jiao, Y., Ma, C., Ju, Y., Zhu, L., SHAO, C., et al. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1315 · Cited by 33
“The interaction between NKG2A/NKG2D and its ligands has been linked to a wide variety of physiologic and pathologic functions (10-26).”
BackgroundThe Multiple Mechanisms of Cell Death Triggered by Resveratrol in Lymphoma and Leukemia
Frazzi, R., & Tigano, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034977 · Cited by 34
“A major modulator of the expression of NKG2D-L at the cell surface is ataxia-telangiectasia mutated (ATM) [48].”
BackgroundNatural Killer Cell Regulation by MicroRNAs in Health and Disease
Leong, J. W., Sullivan, R. P., & Fehniger, T. A. (2012) · BioMed Research International · doi:10.1155/2012/632329 · Cited by 34
“NKG2D is one of the best characterized activating NK cell receptors with ligands that are up regulated in the setting of viral infection or genotoxic stress [91, 92].”
BackgroundMechanisms regulating immune surveillance of cellular stress in cancer
Seelige, R., Searles, S. C., & Bui, J. D. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2597-7 · Cited by 38
“Apart from causing mutations that can lead to the formation of neoantigens activating the immune system, DNA damage can also result in the accumulation of ectopic DNA particles that can function as DAMPs [83] as well as in the upregulation of stress ligands activating immune receptors [62].”
BackgroundPurine nucleotide metabolism regulates expression of the human immune ligand MICA
McCarthy, M. T., Moncayo, G., Hiron, T. K., Jakobsen, N. A., Valli, A., Soga, T., Adam, J., & O’Callaghan, C. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.809459 · Cited by 33
“Previous studies of MICA regulation show that the DNA damage response pathway (19), TLR stimulation (10), histone deacetylation (20), heat shock transformation (21), ionizing radiation (22), growth factor pathway activation (23), and microRNA expression (25) can each induce MICA expression.”
BackgroundInfluence of Innate Immunity on Cancer Cell Stemness
Pastò, A., Consonni, F. M., & Sica, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093352 · Cited by 34
“TME-targeted, NK-mediated responses are triggered via: i) binding of the NKG2D to its ligands (stress-inducible MHC-Ib molecules, DNA damage responses); ii) binding of NKp30 and NKp44 with their respective ligands; and iii) antibody-dependent cellular cytotoxicity (ADCC), where the CD16 Fc receptor on NK cells binds t…”
BackgroundEglenen-Polat, B., Kowash, R., Huang, H.-C., Siteni, S., Zhu, M., Chen, K., Bender, M. E., Mender, I., Stastny, V., Drapkin, B. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44861-8 · Cited by 34
“Upre-gulation of NK cell activating NKG2D ligands by DNA damage sensing proteins ATM and ATR, lead to NK cell activation against tumor cells 54,55 .”
Baugh, R. T., Khalique, H., Page, E., Lei-Rossmann, J., Wan, P. K.-T., Johanssen, T., Ebner, D. V., Ansorge, O., & Seymour, L. W. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008460 · Cited by 33
“19 20 Given the link between the DNA damage response (DDR) and NKG2DL expression, 21 evidence has emerged that DNA damage induced by TMZ and radiation therapy further upregulates NKG2DL on GBM cells and can increase sensitivity to NK cell lysis.”
BackgroundGharagozloo, M., Kalantari, H., Rezaei, A., Maracy, M. R., Salehi, M., Bahador, A., Hassannejad, N., Narimani, M., Sanei, M. H., Bayat, B., et al. (2015) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2015_056 · Cited by 32
“NKG2D ligands are also extensively expressed on solid tumors and some forms of leukemia through induction of cancer-related pathways and oncogenes, but not on normal cells (10, 11).”
Regulation of self-ligands for activating natural killer cell receptors
Lam, R. A., Chwee, J. Y., Bert, N. L., Sauer, M., von Strandmann, E. P., & Gasser, S. (2013) · Annals of Medicine · doi:10.3109/07853890.2013.792495 · Cited by 36
Self-citationKhalifa, J., Mazières, J., Gomez‐Roca, C., Ayyoub, M., & Moyal, E. C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.662236 · Cited by 35
“Once T cells have infiltrated the tumor tissue, they encounter tumor cells with the radiation-induced expression of several surface molecules and receptors, such as MHC-I molecules (10), the TNF-R superfamily (11, 12) and ligands for the NKG2D receptor (13), leading to enhanced tumor cell killing by CD8 T cells and NK…”
BackgroundPereboeva, L., Harkins, L. E., Wong, C. S., & Lamb, L. S. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1662-z · Cited by 32
Espinoza, J. L., Takami, A., Trung, L. Q., & Nakao, S. (2013) · Cancer Science · doi:10.1111/cas.12141 · Cited by 36
Awasthi, A., Samarakoon, A., Dai, X., Wen, R., Wang, D., & Malarkannan, S. (2008) · Genes and Immunity · doi:10.1038/gene.2008.45 · Cited by 32
Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system
Brulois, K., & Jung, J. U. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.06.001 · Cited by 32
“and other cellular stresses such as DNA damage [90] (Fig.”
Nakajima, N. I., Niimi, A., Isono, M., Oike, T., Sato, H., Nakano, T., & Shibata, A. (2017) · Oncology Reports · doi:10.3892/or.2017.5773 · Cited by 32
“DNA damage-dependent NKG2DL activation requires ATM/ATR (7).”
BackgroundInfluentialFusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy
Ding, H., Yang, X., & Wei, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010177 · Cited by 33
“Some chemotherapeutic agents or radiotherapies, as a side-effect, could also induce up-regulation of NKG2DLs by causing DNA damage [23].”
BackgroundRadiotherapy as a New Player in Immuno-Oncology
Wang, S.-J., & Haffty, B. G. (2018) · Cancers · doi:10.3390/cancers10120515 · Cited by 31
NKG2D signaling certifies effector CD8 T cells for memory formation
Pérez, C., Prajapati, K., Burke, B., Plaza-Rojas, L., Zeleznik‐Le, N. J., & Guevara-Patino, J. A. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0531-2 · Cited by 34
Mantovani, S., Varchetta, S., Mele, D., Donadon, M., Torzilli, G., Soldani, C., Franceschini, B., Porta, C., Chiellino, S., Pedrazzoli, P., et al. (2020) · Cancers · doi:10.3390/cancers12123583 · Cited by 34
“NKG2D receptors recognize several molecules, such as MHC class I chain-related molecules (MIC)A/B and the cytomegalovirus UL-16 protein (ULBP1-6), the expression of which is induced on the cell surface as a result of cellular stress conditions, ranging from the activation of DNA-damage response pathways during tumorig…”
BackgroundFantecelle, C. H., Covre, L. P., de Moura, R. G., Guedes, H. L. D. M., Amorim, C. F., Scott, P., Mosser, D. M., Falqueto, A., Akbar, A. N., & Gomes, D. C. O. (2021) · Immunology · doi:10.1111/imm.13410 · Cited by 32
“In addition, several SASP components can also directly modulate the expression of stress ligands including those that bind to NK receptors by immune and non- immune cells [57,58].”
BackgroundXu, Y., Nowsheen, S., & Deng, M. (2023) · Cancers · doi:10.3390/cancers15051619 · Cited by 33
“Stimulation of ATR or ATM—major DNA damage checkpoints—can upregulate the ligands, which activate NKG2D receptors to alert the innate immune system [141].”
BackgroundCisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells
Huang, X., Chen, Y.-T., Song, H., Gui-Chun, H., & Chen, L.-B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i25.3002 · Cited by 31
New Strategies in Ewing Sarcoma: Lost in Translation?
Arnaldez, F. I., & Helman, L. J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0633 · Cited by 31
“Immune-based therapies Lexatumumab Clinical (phase I) (60) NK cell–based therapies Clinical (phase I) (65, 66) CAR Preclinical (67, 68)”
Pignoloni, B., Fionda, C., Dell’Oste, V., Luganini, A., Cippitelli, M., Zingoni, A., Landolfo, S., Gribaudo, G., Santoni, A., & Cerboni, C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502527 · Cited by 34
“Interestingly, expression of some NKG2DL and DNAM-1L can be 90 dependent on the activation of DDR and on ATM/ATR kinases (35-43).”
BackgroundCan NK cells be a therapeutic target in human diseases?
Chan, C. J., Andrews, D. M., & Smyth, M. J. (2008) · European Journal of Immunology · doi:10.1002/eji.200838764 · Cited by 36
NKG2D Is Required for NK Cell Activation and Function in Response to E1-Deleted Adenovirus
Zhu, J., Huang, X., & Yang, Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002771 · Cited by 31
“Previous studies in other models have shown that NKG2D ligands can be induced in response to cellular stress, such as the response to DNA damage (28), infection (29), as well as TLR stimulation (30).”
Peeling back the layers of immunogenicity in Cas9-based genomic medicine
Stigzelius, V., Cavallo, A. L., Chandode, R. K., & Nitsch, R. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.06.045 · Cited by 33
“162,163 NKG2D receptor is a costimulatory membrane protein expressed by cytolytic immune cells, which upon ligand binding positively regulates effector cell activity.”
Zhang, Q., Benedetti, E., Deater, M., Schubert, K. M., Major, A. M., Pelz, C., Impey, S., Loza, L. I. M., Rathbun, R. K., Kato, S., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.10.014 · Cited by 31
“Recentwork has clearly shown that DNA damage can activate innate immunity (Gasser et al., 2005) by signals emanating from the”
BackgroundImmuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing
Bernier, J. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.11.001 · Cited by 34
Listening to each other: Infectious disease and cancer immunology
Vance, R. E., Eichberg, M. J., Portnoy, D. A., & Raulet, D. H. (2017) · Science Immunology · doi:10.1126/sciimmunol.aai9339 · Cited by 31
“The DNA damage response, often activated in transformed cells and pre cancerous lesions, is also now appreciated to stimulate a diverse set of immune responses (10).”
BackgroundSelf-citationThe plant WEE1 kinase is involved in checkpoint control activation in nematode‐induced galls
Cabral, D., Banora, M. Y., Antonino, J. D., Rodiuc, N., Vieira, P. C., Coelho, R. R., Chevalier, C., Eekhout, T., Engler, G., Veylder, L. D., et al. (2019) · New Phytologist · doi:10.1111/nph.16185 · Cited by 30
“All rights reserved pathogens (Song and Bent, 2014; Menendez et al., 2011; Gasser et al., 2005;).”
BackgroundPharmacological targeting of natural killer cells for cancer immunotherapy
Miyazato, K., & Hayakawa, Y. (2020) · Cancer Science · doi:10.1111/cas.14418 · Cited by 34
Sodji, Q. H., Nambiar, D. K., Viswanathan, V., von Eyben, R., Colburg, D. R. C., Binkley, M. S., Li, C. G., Olcina, M. M., Chang, D. T., Le, Q., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0069 · Cited by 30
“The activation of DNA damage checkpoint pathway initiated by ataxia telangiectasia mutated (ATM) or ataxia telangiectasia mutated and rad3-related (ATR) kinases following radiotherapy leads to the upregulation of the ligands of the NK cell–activating receptor NKG2D onmalignant cells thus enhancing NK cell cytotoxic ac…”
BackgroundDeveloping stratified epithelia: lessons from the epidermis and thymus
Roberts, N. A., & Horsley, V. (2014) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.146 · Cited by 31
Park, M.-J., Bae, J.-H., Chung, J. S., Kim, S.-H., & Kang, C. (2011) · Immunological Investigations · doi:10.3109/08820139.2010.551435 · Cited by 30
Murakami, S., Noguchi, T., Takeda, K., & Ichijo, H. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00551.x · Cited by 32
Heo, W., Lee, Y. S., SON, C. H., Yang, K., Park, Y. S., & BAE, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2918 · Cited by 30
“Previous reports have suggested that this upregulation is associated with the ATM-ATR pathway at the translational level (15,16).”
BackgroundPhillips, L., Gould, E. A., Babu, H., Krams, S. M., Palmer, T. D., & Martinez, O. M. (2013) · Stem Cells · doi:10.1002/stem.1422 · Cited by 30
Mboko, W. P., Mounce, B. C., Wood, B. M., Kulinski, J. M., Corbett, J. A., & Tarakanova, V. L. (2012) · Journal of Virology · doi:10.1128/jvi.07119-11 · Cited by 34
“Irradiation was also shown to stimulate the expression of ligands for NKG2D, an activating NK receptor; however, the involvement of immune signaling pathways in NKG2D ligand expression has not been defined (12).”
BackgroundChanut, R., & Pétrilli, V. (2019) · médecine/sciences · doi:10.1051/medsci/2019095 · Cited by 30
Bae, J., Kim, S.-J., Kim, M.-J., Oh, S.-O., Chung, J., Kim, S.-H., & Kang, C. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2011.02109.x · Cited by 34
Schulz, U., Kreutz, M. P., Multhoff, G., Stoelcker, B., Köhler, M., Andreesen, R., & Holler, E. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02435.x · Cited by 30
Akatsuka, A., Ito, M., Yamauchi, C., Ochiai, A., Yamamoto, K., & Matsumoto, N. (2010) · International Immunology · doi:10.1093/intimm/dxq430 · Cited by 32
Stimulating natural killer cells to protect against cancer: recent developments
Gillgrass, A. E., & Ashkar, A. A. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.102 · Cited by 31
Pellicciotta, I., Cortez‐Gonzalez, X., Šášik, R., Reiter, Y., Hardiman, G., Langlade‐Demoyen, P., & Zanetti, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1014 · Cited by 31
“Levels of acetylation also play a role in the differentiation of T cells (6, 7) and in the expression of ligands for natural killer (NK) cells (8).”
Sidorova, J. M. (2017) · Cell Stress · doi:10.15698/cst2017.12.114 · Cited by 32
“Over the past decade, studies have begun to make connections between DNA damage response and the immune response to self-DNA [155, 156] mediated by a cytosolic DNA sensor cGAS and a downstream adaptor STING (for review [157]).”
BackgroundFletcher, S. C., Grou, C. P. O., Legrand, A. J., Chen, X., Söderström, K., Poletto, M., & Dianov, G. L. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1291 · Cited by 32
“Interestingly, expression of some activating NKG2D ligands is proposed to depend on the ATM/ATR signaling axis (29,30,38).”
Background
Metadata
- Authors
- Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- University of Pennsylvania (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature
- Published
- 2005-07-03
- Volume
- 436
- Issue
- 7054
- Pages
- 1186-1190
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC1352168
- OpenAlex
- W1969464492
- Cited by
- 1,308
- References
- 28
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 26 · 2023: 51 · 2022: 57 · 2021: 60 · 2020: 72 · 2019: 62 · 2018: 62 · 2017: 64 · 2016: 63 · 2015: 71 · 2014: 85 · 2013: 74 · 2012: 68
- FWCI
- 28.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Prostate Cancer Foundation
- National Institutes of Health
- National Cancer Institute (R01CA093678)
- National Institute of Allergy and Infectious Diseases (R01AI039642)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- NKG2D, NKG2D ligands, DNA damage response, innate immunity, ATM kinase, ATR kinase, Chk1, genotoxic stress, natural killer cells, CD8+ T cells, cancer cell lines, siRNA
- MeSH terms
- Checkpoint Kinase 1, Animals, Cell Transformation, Neoplastic, DNA Damage, DNA Replication, Fibroblasts, Humans, Immune System, Immunity, Innate, Kinetics, Ligands, Mice, Inbred C57BL, Phosphorylation, Protein Kinases, Receptors, Immunologic, Up-Regulation, Aphidicolin, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cell Line, Tumor, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.